Research of Embryotoxicity of {\sl Toosendanin} in Kunming Mice

Zhang Xian-fu,Jianhua Wang,Shufang Zhang,Ying Liu,Fan Li,Shi Xiayun

2005-01-01

Abstract:Virgin female mice weighting 18～25g were superovulated, and then mated with male mice. The acquired pregnant mice were divided into 6 groups for embryotoxicity research of toosendanin on embryo of mice in 2-cell, morula, blastocysts stages. Control group was set up in each of these three stages. Every pregnant mouse of treated and control groups in the three stages was given the dose of 1/30 LD_(50) toosendanin and same amount of PBS 2 times by intraperitoneal injection respectively. Superovulation need not be carried out for embryotoxicity study of toosendanin in implantation stage, but each pregnant mice in treated and control group was given the dose of 1/30 LD_(50) toosendanin and PBS 3 times by intraperitoneal injection respectively. Finally, the number and configuration of embryo in uteri of all groups were counted and examined. Results indicated that total embryo of treated group in 2-cell, morula and blastocysts stages had no significance difference comparing with corresponding control group (P 0.05); Number of normal and abnormal embryo of treated group in 2-cell stage had no significance difference comparing with control group either (P 0.05); Number of normal and abnormal embryo of treated group in morula and blastocysts stages had great significance difference comparing with corresponding control group (P 0.01). Due to injection to the treated group 3 times in implantation stage, almost all the fetuses in uteri had been melting, and counting of them could not be performed, while healthy fetuses could be seen and counted clearly in control group. There were only mild histological changes founded in maternal heart, liver, lung, kidney and uteri in all treated groups. All above means that the intraperitoneal injection of a small amount of toosendanin to pregnant Kunming mice may has special embryotoxicity.